Novel therapeutic approaches for gastrointestinal malignancies
 
A termék adatai:

ISBN13:9789811554704
ISBN10:9811554706
Kötéstípus:Keménykötés
Terjedelem:259 oldal
Méret:235x155 mm
Súly:576 g
Nyelv:angol
Illusztrációk: 14 Illustrations, black & white; 39 Illustrations, color
0
Témakör:

Novel therapeutic approaches for gastrointestinal malignancies

 
Kiadás sorszáma: 1st ed. 2020
Kiadó: Springer
Megjelenés dátuma:
Kötetek száma: 1 pieces, Book
 
Normál ár:

Kiadói listaár:
EUR 106.99
Becsült forint ár:
44 149 Ft (42 047 Ft + 5% áfa)
Miért becsült?
 
Az Ön ára:

40 617 (38 683 Ft + 5% áfa )
Kedvezmény(ek): 8% (kb. 3 532 Ft)
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
 
Beszerezhetőség:

Bizonytalan a beszerezhetőség. Érdemes még egyszer keresni szerzővel és címmel. Ha nem talál másik, kapható kiadást, forduljon ügyfélszolgálatunkhoz!
Nem tudnak pontosabbat?
 
 
Rövid leírás:

This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents.



Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies.

Hosszú leírás:

This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents.



Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies.

Tartalomjegyzék:
Chapter 1. Role of selected transcription factors in pancreatic and colorectal cancer growth and metastasis.
- Chapter 2. Adiponectin in gastrointestinal malignancies.
- Chapter 3. Small molecule
-targeted therapies for GI cancers: success and failures.
- Chapter 4. Epigenetic biomarkers for the detection of Gastrointestinal Cancers.
- Chapter 5. CD151:  A Lateral organizer and modulator of Tumor microenvironment in gastrointestinal cancers.
- Chapter 6. Targeting Pathways in GI Malignancies.
- Chapter 7. Identification of Potential Key Genes Involved In Progression of Gastric Cancer Using Bioinformatics Analysis.
- Chapter 8. Recent Development in the biomarkers for the gastric cancer.
- Chapter 9. Gastric Cancer and it?s remedy.
- Chapter 10. An intergenic variant rs4779584 between SCG5 and GREM1 contributes to the increased risk of colorectal cancer: A meta
-analysis.
- Chapter 11. Phytochemicals plus nanomaterial?s on colorectal cancer.
- Chapter 12. Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones?.
- Chapter 13. Tumor Biomarkers and Diagnosis of Pancreatic Adenocarcinoma.
- Chapter 14. Immunotherapy in Gastrointestinal Malignancies.
- Chapter 15. The Role of HIF
-1? in Hepatocellular Carcinoma.